A randomised controlled comparison of Campath-Tacrolimus vs IL2R MoAb-tacrolimus/mycophenolate mofetil as induction-maintenance immunosuppression in kidney transplantation.
Phase of Trial: Phase IV
Latest Information Update: 31 Jul 2014
At a glance
- Drugs Alemtuzumab; Daclizumab; Mycophenolate mofetil; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms CamTac
- 09 Feb 2012 Actual end date (Dec 2008) added as reported by ISRCTN: Current Controlled Trials.
- 09 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 02 Sep 2009 Results reported at ESOT 2009.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History